[posting]61751008[/posting]Bausch Health Licenses Clearside Biomedical's XIPERE\u2122 (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis
|
[posting]61751008[/posting]Bausch Health Licenses Clearside Biomedical's XIPERE\u2122 (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis |
|
| aus der Diskussion: | CLSD (Mkap $39 M) (Cash $65 M) NDA bei der FDA eingereicht =200%+ Chance |
| Autor (Datum des Eintrages): | Carola11 (23.10.19 13:59:26) |
| Beitrag: | 848 von 1,108 (ID:61751101) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |